Modulation of the apelin/APJ system in heart failure and atherosclerosis in man
Open Access
- 26 April 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (7) , 1785-1795
Abstract
Background and purpose: The aim of this study was to determine whether the apelin/APJ system is altered in human cardiovascular disease by investigating whether the expression of apelin or its receptor is altered at the protein level. Experimental approach: Radioligand binding studies were used to determine apelin receptor density in human cardiac tissues. Apelin peptide levels in cardiovascular tissues were determined by radioimmunoassay. In vitro pharmacology was used to assess vasoactive properties of apelin in human coronary artery. Localization of apelin and its receptor in coronary artery was determined using immunohistochemistry. Key results: Apelin receptor density was significantly decreased in left ventricle from patients with dilated cardiomyopathy or ischaemic heart disease compared with controls, but apelin peptide levels remained unchanged. Apelin was up‐regulated in human atherosclerotic coronary artery and this additional peptide localized to the plaque, colocalizing with markers for macrophages and smooth muscle cells. Apelin potently constricted human coronary artery. Conclusions and implications: We have detected changes in the apelin/APJ system in human diseased cardiac and vascular tissue. The decrease in receptor density in heart failure may limit the positive inotropic actions of apelin, contributing to contractile dysfunction. The contribution of the increased apelin levels in atherosclerotic coronary artery to disease progression remains to be determined. These data suggest a potential role for the apelin/APJ system in human cardiovascular disease.Keywords
This publication has 40 references indexed in Scilit:
- International Union of Basic and Clinical Pharmacology. LXXIV. Apelin Receptor Nomenclature, Distribution, Pharmacology, and FunctionPharmacological Reviews, 2010
- In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoidsRegulatory Peptides, 2007
- Requirement of Apelin-Apelin Receptor System for Oxidative Stress-Linked AtherosclerosisThe American Journal of Pathology, 2007
- The 212A Variant of the APJ Receptor Gene for the Endogenous Inotrope Apelin is Associated With Slower Heart Failure Progression in Idiopathic Dilated CardiomyopathyJournal of Cardiac Failure, 2007
- Impaired Heart Contractility in Apelin Gene–Deficient Mice Associated With Aging and Pressure OverloadCirculation Research, 2007
- Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injuryBasic Research in Cardiology, 2007
- Hypoxia inducible factor regulates the cardiac expression and secretion of apelinThe FASEB Journal, 2007
- Idiopathic Dilated CardiomyopathyNew England Journal of Medicine, 1994
- A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11Gene, 1993